We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (376)
- Scheduling (national classification system) (174)
- Safety monitoring and information (31)
- COVID-19 (11)
- Manufacturing (11)
- Advertising (9)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Compliance and enforcement (5)
- Sunscreens (5)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Breast implant hub (1)
- Import and export (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
764 result(s) found, displaying 351 to 375
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 17 August 2021
-
Scheduling decisions (final)Notice of final decisions to amend the Poisons Standard - ACMS #32, Joint ACMS-ACCS #26, ACCS #29 (November 2020).
-
Scheduling submissionsPublic submissions made in response to the interim decisions published on 3 February 2021
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Scheduling decisions (interim)Publication of interim decisions for substances referred to the March 2021 ACMS/ACCS meetings have been delayed.
-
Corporate reportsThe PVIP aims to strengthen and broaden the TGA's post-market monitoring activities and protect public health
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting statement.
-
Meeting statementsDetails for meeting 1 of Australian Dental Sector Working Group held on 19 April 2021.
-
Meeting statementsAdvisory Committee on Complementary Medicines (ACCM) meeting statement
-
Corporate reportsRead our clinician information sheet on opioid analgesic tapering.
-
Scheduling decisions (final)Decisions to be included in the June 2021 and October 2021 Poisons Standards
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement.
-
-
Corporate reportsThe July-December 2020 Half Yearly Performance Statistics Report is now available
-
Corporate reportsThe Australian Government has accepted all 22 recommendations
-
Corporate reportsGuidance for procurement areas in hospitals, aged care residential facilities and other facilities.
-
Corporate reportsThis Points to Consider document lays out a regulatory approach for updating authorised coronavirus vaccines should mutations at any time make them less efficacious due to insufficient cross-reactivity.
-
Meeting statementsDetails about meeting 1 for the Medical Device Consumer Working Group (MDCWG) held in 2019.
-
Meeting statementsDetails about meeting 2 for the Medical Device Consumer Working Group (MDCWG) held in 2020.
-
Meeting statementsDetails about meeting 3 for the Medical Device Consumer Working Group (MDCWG) held in 2020.
-
Meeting statementsDetails about meeting 4 for the Medical Device Consumer Working Group (MDCWG) held in 2020.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-